Ernexa Therapeutics (ERNA) Other Non-Current Liabilities (2010 - 2026)
Ernexa Therapeutics (ERNA) reported Other Non-Current Liabilities of $1,000 for Q2 2026, down 99.1% from $113,000 a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Ernexa Therapeutics (ERNA) Other Non-Current Liabilities (2010 - 2026) Analysis & Trends
At the end of FY2025, Ernexa Therapeutics posted Other Non-Current Liabilities of $43,000, down 61.3% from FY2024.
- Other Non-Current Liabilities has declined for three consecutive years, though with a five-year compound annual growth rate of 13.3% (FY2020 to FY2025).
- By year, Other Non-Current Liabilities came in at $111,000 in FY2024 (-4.3%), $116,000 in FY2023 (-65.0%), $331,000 in FY2022 (+589.6%) and $48,000 in FY2021 (+108.7%).
- Five-year quarterly Other Non-Current Liabilities spans a low of $1,000 in Q1 2026 and a high of $19.36 million in Q3 2021.
- Year over year, Other Non-Current Liabilities has now declined in each of the last four quarters, with an average decline of 52.6% over the last seven quarters.
- The high point for year-over-year Other Non-Current Liabilities in five years was Q4 2022 (growth of 589.6%); the low point was Q2 2026 (a decline of 99.1%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $1,000 (Q1 2026), $43,000 (Q4 2025) and $112,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn |
| 10 | Ernexa Therapeutics | 2.45 Mn | -16.70 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1,000.00 |
| Mar 31, 2026 | 1,000.00 |
| Dec 31, 2025 | 43,000.00 |
| Sep 30, 2025 | 112,000.00 |
| Jun 30, 2025 | 113,000.00 |
| Mar 31, 2025 | 152,000.00 |
| Dec 31, 2024 | 153,000.00 |
| Sep 30, 2024 | 10.59 Mn |
| Jun 30, 2024 | 175,000.00 |
| Mar 31, 2024 | 377,000.00 |
| Dec 31, 2023 | 307,000.00 |
| Sep 30, 2023 | 272,000.00 |
| Jun 30, 2023 | 292,000.00 |
| Mar 31, 2023 | 1.23 Mn |
| Dec 31, 2022 | 331,000.00 |
| Sep 30, 2022 | 2.32 Mn |
| Jun 30, 2022 | 2.57 Mn |
| Mar 31, 2022 | 13.36 Mn |
| Dec 31, 2021 | 48,000.00 |
| Sep 30, 2021 | 19.38 Mn |
API Access
Ernexa Therapeutics Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=ERNA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "ERNA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=ERNA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();